Search Results

Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable, Human Acellular Vessels at commercial scale, announced the issuance of four new ICD-10-PCS codes by the U.S. Centers for Medicare & Medicaid Services ICD-10 Coordination and Maintenance Committee.

CGI Federal Inc., a wholly-owned U.S. operating subsidiary of CGI Inc., has been awarded a single award, firm-fixed price contract by the Centers for Medicare & Medicaid Services to help improve access to Medicare for millions of beneficiaries by modernizing the agency’s Health Plan Management System.

The Centers for Medicare & Medicaid Services revised the National Coverage Determination of allogeneic hematopoietic stem cell transplantation for individuals with myelodysplastic syndromes due to a request for reconsideration prepared by The American Society of Hematology, the American Society for Transplantation and Cellular Therapy®, the National Marrow Donor Program, and the Center for International Blood and Marrow Transplant Research on January 5, 2024.

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the biopharma industry. The new tax law also cuts Medicaid funding, posing a minimal risk to pharma’s bottomlines and potentially jeopardizing hospitals’ 340B status. It does not, however, include new rules for pharmacy benefit managers that had been in an earlier draft.

Invivyd, Inc. announced that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code covering product reimbursement for PEMGARDA.